Swan Capital’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.17K Hold
69
﹤0.01% 352
2025
Q4
$2.03K Hold
69
﹤0.01% 331
2025
Q3
$1.74K Hold
69
﹤0.01% 334
2025
Q2
$1.66K Hold
69
﹤0.01% 339
2025
Q1
$1.58K Hold
69
﹤0.01% 254
2024
Q4
$1.75K Hold
69
﹤0.01% 240
2024
Q3
$1.72K Hold
69
﹤0.01% 234
2024
Q2
$2.05K Buy
+69
New +$1.91K ﹤0.01% 195

Other funds holding RTO

Swan Capital's RTO Position: Q1 2026 in Review

Swan Capital held its Rentokil (RTO) position steady in Q1 2026 at 69 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #352.

Swan Capital first reported a position in RTO in Q2 2024 and has held it in 8 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Swan Capital held 69 shares of Rentokil worth $2.17K as of Q1 2026.
  • Swan Capital left its Rentokil share count unchanged in Q1 2026.
  • Rentokil made up ﹤0.01% of Swan Capital's portfolio in Q1 2026, its #352 holding.
  • Swan Capital first reported a position in Rentokil in Q2 2024 and has held it in 8 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.